Position in LLY
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$5,892,800
+$1,568,042 QoQ
Shares Held
4,913
+4.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.71%
of 13F equity value
Holder Rank
#1,585
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FLAGSHIP HARBOR ADVISORS, LLC holds $34,099,548 across 12 Drug Manufacturers - General names. LLY ranks #4 (17.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
30,533 | $7,754,466 | |
| 2 | ABBV |
AbbVie Inc.
|
28,893 | $7,270,634 | |
| 3 | MRK |
Merck & Co., Inc.
|
50,083 | $6,435,665 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
4,913 | $5,892,800 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
29,492 | $1,699,329 | |
| 6 | PFE |
Pfizer Inc
|
70,067 | $1,687,213 | |
| 7 | AMGN |
Amgen Inc
|
2,672 | $967,584 | |
| 8 | AZN |
Astrazeneca PLC
|
2,895 | $548,949 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,892,800 | 4,913 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $4,324,758 | 4,702 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $5,139,120 | 4,782 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $4,832,842 | 6,334 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $4,853,353 | 6,226 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $5,111,556 | 6,189 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $5,050,424 | 6,542 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $6,123,617 | 6,912 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $6,284,242 | 6,941 | Shares | Sole | 2025-12-02 | |
| 2024-03-31 | $5,031,067 | 6,467 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $3,420,574 | 5,868 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $2,826,915 | 5,263 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $2,474,338 | 5,276 | Shares | Sole | 2023-07-11 | |
| 2023-03-31 | $1,546,420 | 4,503 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $1,353,242 | 3,699 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $1,224,849 | 3,788 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $1,318,643 | 4,067 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $1,227,381 | 4,286 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $1,123,662 | 4,068 | Shares | Sole | 2022-02-17 | |
| 2021-09-30 | $869,672 | 3,764 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $863,913 | 3,764 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $683,948 | 3,661 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $547,885 | 3,245 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $446,428 | 3,016 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $459,868 | 2,801 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $357,204 | 2,575 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||